文献速递临床微生物分子诊断

法国流行病学背景下产碳青霉烯酶肠杆菌检测与分型新专家规则的评估

Evaluation of new expert rules for the detection and differentiation of carbapenemase-producing Enterobacterales within the French epidemiological context.
PubMed 文献 · J Clin Microbiol · 2026-05-28

本研究评估VITEK2 Advanced Expert System联合VITEK2药敏结果检测产碳青霉烯酶肠杆菌(CPE)的性能,以及BIOART专家规则识别碳青霉烯酶类型的能力。对244株法国流行病学代表性菌株(145株CPE、51株非CPE碳青霉烯耐药肠杆菌、48株非CRE)进行药敏试验,并评估OXA-244/484专用规则。VITEK2 N436/AES与CA-SFM算法检测CPE敏感性相似(93.8% vs 97.2%),特异性分别为53.5% vs 49.5%。专用OXA-244/484规则实现100%检测。

要点

  • VITEK2 N436/AES与CA-SFM算法检测CPE敏感性相似,多数检测错误涉及OXA-244/484生产者。
  • 应用OXA-244/484专用规则可实现100%检测,弥补难识别菌株的诊断缺口。
  • BIOART规则对NDM和KPC生产者分型表现较好,但OXA-48-like和VIM单类正确赋值率较低。

核心结论

  • VITEK2 AES/BIOART整合方案为CPE筛查和分类提供了有效方法,尤其对NDM和KPC生产者。

研究设计与样本

  • 对244株法国流行病学代表性菌株(145株CPE、51株非CPE CRE、48株非CRE)进行VITEK2(N436+XN28卡)和纸片扩散法药敏试验。
  • 在36株OXA-244/484生产者中评估专用OXA-244/484规则。

主要发现

  • VITEK2 N436/AES与CA-SFM算法检测CPE敏感性分别为93.8%和97.2%,特异性分别为53.5%和49.5%。
  • 多数检测错误涉及OXA-244/484生产者,应用专用规则后检测率达100%。
  • BIOART规则在83例中识别单一碳青霉烯酶类且未报告其他机制,30例报告正确类别伴其他机制,6例未分配碳青霉烯酶类,5例分配错误类别。
  • 单一正确碳青霉烯酶类赋值率:NDM生产者97.5%,OXA-48-like生产者54.5%,VIM生产者57.1%。

临床怎么用

  • 整合VITEK2 AES与BIOART专家规则可用于CPE筛查和碳青霉烯酶类预测,尤其对NDM和KPC生产者。
  • 对疑似OXA-244/484生产者应应用专用规则以提高检出率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The increasing prevalence of carbapenemase-producing Enterobacterales (CPE) requires reliable diagnostic tools. This study evaluated the performance of the VITEK2 Advanced Expert System, a software interpretation program combined with VITEK2 AST results, for CPE detection, and the ability of BIOART expert rules to identify carbapenemase types. Antimicrobial susceptibility testing was performed using VITEK2 (N436 + XN28 cards) and disk diffusion on a collection of 244 isolates representative of French epidemiology, including 145 CPE, 51 non-CPE carbapenem-resistant Enterobacterales (CRE), and 48 non-CRE. A dedicated OXA-244/484 rule was assessed on a collection of 36 OXA-244/484 producers, known to be difficult to detect. The VITEK2 N436/AES and CA-SFM algorithm demonstrated similar sensitivities (93.8% vs 97.2%) and specificities (53.5% vs 49.5%) for CPE detection. Most detection errors involved OXA-244/484 producers. Application of the dedicated OXA-244/484 rule enabled 100% detection. BIOART rules identified the single carbapenemase class with no other mechanism reported in 83 cases, the correct class with additional mechanisms reported in 30 cases, and no carbapenemase class, or an incorrect carbapenemase class were assigned in 6 and 5 cases, respectively. Twelve isolates were outside the scope of BIOART rule (IMI or multiple carbapenemases). Single correct carbapenemase class assignment was achieved in 97.5% of NDM producers, 54.5% of OXA-48-like producers, and 57.1% of VIM producers. All KPC producers were correctly identified as KPC producers, although carbapenem impermeability was systematically co-reported, preventing single unambiguous assignment. The integrated VITEK2 AES/BIOART solution provides an efficient approach for CPE screening and classification, particularly for NDM and KPC-producers. IMPORTANCE: Rapid and reliable detection of carbapenemase-producing Enterobacterales (CPE) is essential for infection control, epidemiological surveillance, and optimized antimicrobial therapy. As the prevalence and diversity of carbapenemases increase, diagnostic tools capable not only of detecting CPE but also predicting carbapenemase classes are increasingly needed to guide treatment decisions. In Europe, the emergence of OXA-48-like variants such as OXA-244 and OXA-484, which exhibit low hydrolytic activity to carbapenems and temocillin, complicates routine phenotypic detection and may lead to diagnostic failure. This study evaluates an automated solution integrating the VITEK2 Advanced Expert System and BIOART expert rules for CPE detection and classification in a representative French epidemiological context. We demonstrate that this integrated approach provides accurate and rapid screening, with good performance for carbapenemase class prediction, particularly for NDM and KPC producers. The implementation of a dedicated rule significantly improves detection of difficult-to-identify OXA-244/OXA-484 producers, addressing an important diagnostic gap.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Emeraud C, Abad L, Crolet V, et al. Evaluation of new expert rules for the detection and differentiation of carbapenemase-producing Enterobacterales within the French epidemiological context. J Clin Microbiol. 2026. PMID: 42207690. doi:10.1128/jcm.00222-26

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。